Market revenue in 2020 | USD 65.4 million |
Market revenue in 2028 | USD 91.0 million |
Growth rate | 4.2% (CAGR from 2020 to 2028) |
Largest segment | Reagent-based |
Fastest growing segment | Reagent-based |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagent-based, Physical Disruption |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Bio-Rad Laboratories Inc, Roche Holding AG ADR, Qiagen NV, Danaher Corp, Miltenyi Biotec, IDEX Corp, BD, Claremont BioSolutions, Parr Instrument Company, Covaris, Cell Signaling Technology, Qsonica |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell lysis and disruption market will help companies and investors design strategic landscapes.
Reagent-based was the largest segment with a revenue share of 62.39% in 2020. Horizon Databook has segmented the Brazil cell lysis and disruption market based on reagent-based, physical disruption covering the revenue growth of each sub-segment from 2018 to 2028.
In 2018, the Brazilian president declared a reduction of 44% in the federal science budget of the country. Moreover, scientists and research institutions do not expect any help from state governments as many government agencies such as Rio de Janiero’s funding agency are facing financial challenges.
In addition, the country’s standalone ministry of science is now merged with telecommunications to form a new Ministry of Science, Technology, Innovations, and Communications (MCTIC). Therefore, Brazil’s escalating fiscal deficits have resulted into reduction in funds for research, thereby, restricting the market growth.
However, the country has strategically collaborated with other nations with initiatives such as Canada– Brazil Joint Committee for Cooperation on Science, Technology, and Innovation along with being a member of BRICS. Under the joint committee for science, technology, and innovation.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil cell lysis and disruption market , including forecasts for subscribers. This country databook contains high-level insights into Brazil cell lysis and disruption market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account